Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
boston blog main
fda
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boston top stories
clinical trials
ipo
new york
novartis
san diego blog main
san diego top stories
sanofi
startups
abbvie
acetylon pharmaceuticals
akouos
alex gorsky
alirocumab
allergan
amag pharmaceuticals
ambys medicines
amgen
amunix
anirvan ghosh
ashley mcevoy
astrazeneca
auris health
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
What
deal
4
×
medicines
billion
cash
new
plans
startup
acquire
acquiring
acquisitions
agreed
aiming
ambys
announced
auris
big
bio
biotech
brings
builds
buy
ceo
cholesterol
collabs
company
company’s
compound
control
covid
daniel
deadly
debuted
developer
diseases
drug
fda
formed
future
gilead
gilead’s
Language
unset
Current search:
biotech
×
" new york top stories "
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?